Home > News > Drug find worth $700 million
March 10th, 2008
Drug find worth $700 million
Abstract:
In a chemist's version of a winning PowerBall ticket, Richard Silverman's discovery eventually became a blockbuster drug that showered him and Northwestern University with more than $700 million in royalties.
Still, there was disappointment along the way. Once Pfizer Inc., the giant pharmaceutical concern, took control of the drug's development, Silverman was pushed aside.
"I was an outsider," said Silverman, 61. "There was no talk with their scientists. No comments. They had a launch party for the drug, and I asked to come. Nope. No party for me. They take your stuff and tell you to go away."
While it is common for university professors in places like California's Silicon Valley and Boston's Highway 128 to commercialize their research, it is less common in the Midwest, said Jon Wasserman, a Chicago-based attorney specializing in nanotechnology issues.
Source:
chicagotribune.com
Bookmark:
| Related News Press |
News and information
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Spinel-type sulfide semiconductors to operate the next-generation LEDs and solar cells For solar-cell absorbers and green-LED source October 3rd, 2025
Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||